• 1. Department of Respiratory and Critical Care Medicine, Chengdu First People’s Hospital, Chengdu, Sichuan 610041, P. R. China;
  • 2. Department of Geratic Respiratory Medicine, Sichuan Academy of Medical Sciences & Provincial People’s Hospital, Chengdu, Sichuan 610072, P. R. China;
  • 3. Department of Radiology, Chengdu First People People’s Hospital, Chengdu, Sichuan 610041, P. R. China;
ZUO Qiunan, Email: 179538224@qq.com
Export PDF Favorites Scan Get Citation

Objective To investigate the expression and significance of cysteine-rich protein 61 (Cyr61) in patients with chronic obstructive pulmonary disease (COPD).Methods Between September 2017 and September 2018, 27 patients with benign tumor needing to surgical therapy, were divided into COPD group (15 patients) and non-COPD group (12 patients), according to lung function. Lung tissues were selected at the distance at least 5 cm from the tumor. The levels of Cyr61, interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) in serum were determined by enzyme-linked immunosorbent assay. Meanwhile, the expressions of Cyr61 in lung tissues were measured by immunohistochemistry technology between two groups. Furthermore, correlations among Cyr61, IL-8, MCP-1, smoking index, forced expiratory volume in the 1st second as percentage of predicted values (FEV1%pred), scores of COPD Assessment Test (CAT) were analyzed.Results Serum Cyr61, IL-8, MCP-1 levels were significantly higher in patients with COPD than in the non-COPD group (P<0.05), (2409.80±893.87)pg/mL, (76.27±10.53)pg/mL, (173.67±42.64)pg/mL vs. (1065.42±158.83)pg/mL, (57.33±8.29)pg/mL, (138.42±27.62)pg/mL, respectively. By immunohistochemistry technology, the expression levels of Cyr61 in lung epithelial cells and in lung macrophage cells of COPD patients were higher than in the non-COPD group (P<0.01). Positive correlations were found between serum IL-8, serum MCP-1, CAT scores, smoking index and serum Cyr61 (r=0.674, 0.566, 0.602, and 0.755, P=0.006, 0.028, 0.018, and 0.003, respectively) in COPD group. Furthermore, in COPD group, there were also positive correlations between serum IL-8, serum MCP-1, CAT scores, smoking index and intrapulmonary Cyr61 (r=0.542, 0.635, 0.809, and 0.580, P=0.037, 0.011, 0.001, and 0.038 respectively). Inverse correlation was found between serum Cyr61 and FEV1%pred (r=–0.772, P<0.01), and the same as between intrapulmonary Cyr61 and FEV1%pred (r=–0.683, P<0.01).Conclusions Cyr61 highly expresses in serum and in lung tissues of patients with COPD, and its expression is correlated with lung function of patients. The results indicate that Cyr61 may interact with IL-8 and MCP-1 in the pathogenesis of chronic obstructive pulmonary disease.

Citation: WANG Hui, ZUO Qiunan, FENG Li. Expressions and significance of cysteine-rich protein 61 in patients with chronic obstructive pulmonary disease. Chinese Journal of Respiratory and Critical Care Medicine, 2020, 19(5): 441-445. doi: 10.7507/1671-6205.202002115 Copy

  • Previous Article

    The predictive effect of fractional exhaled nitric oxide measurement on treatment in COPD patients with different phenotype of acute exacerbation frequency
  • Next Article

    Diagnostic value of soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid for Acinetobacter baumannii infection and colonization in the lungs